(Q40937898)

25 September 2017

Circulatory and anti-platelet effects of intravenous prostacyclin in healthy men (English)

1 reference

https://api.crossref.org/works/10.1016/S0031-6989(78)80053-8

26 June 2022

1 reference

https://api.crossref.org/works/10.1016/S0031-6989(78)80053-8

26 June 2022

1

Szczeklik A

1 reference

25 September 2017

2

R. J. Gryglewski

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A358212

26 June 2022

3

R. Nizankowski

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A358212

26 June 2022

author name string

J. Musiał

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A358212

26 June 2022

R. Pietoń

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A358212

26 June 2022

J. Mruk

series ordinal

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A358212

26 June 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=358212

26 June 2022

publication date

1 June 1978

1 reference

25 September 2017

12

1 reference

full work available at URL

inferred from page(s)

https://api.elsevier.com/content/article/PII:S0031698978800538?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0031-6989(78)80053-8

https://api.elsevier.com/content/article/PII:S0031698978800538?httpAccept=text/plain

26 June 2022

1 reference

https://api.crossref.org/works/10.1016/S0031-6989(78)80053-8

Pharmacological research communications

26 June 2022

published in

1 reference

25 September 2017

10

1 reference

25 September 2017

545-556

1 reference

25 September 2017

6

1 reference

Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides

25 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0031-6989%2878%2980053-8

7 January 2021

An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation

1 reference

https://api.crossref.org/works/10.1016%2FS0031-6989%2878%2980053-8

7 January 2021

The generation of prostacyclin by arteries and by the coronary vascular bed is reduced in experimental atherosclerosis in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0031-6989%2878%2980053-8

7 January 2021

Prostacyclin (PGX) is the endogenous metabolite responsible for relaxation of coronary arteries induced by arachindonic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0031-6989%2878%2980053-8

7 January 2021

Aspirin as an Antiplatelet Agent: Template Bleeding Time as a Monitor of Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0031-6989%2878%2980053-8

7 January 2021

Modulation of human platelet adenylate cyclase by prostacyclin (PGX)

1 reference

https://api.crossref.org/works/10.1016%2FS0031-6989%2878%2980053-8

7 January 2021

Platelet activation in acute cerebral ischaemia. Serial measurements of platelet function in cerebrovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0031-6989%2878%2980053-8

7 January 2021

In vivo method for quantitation for anti-platelet potency of drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0031-6989%2878%2980053-8

7 January 2021

Sulfinpyrazone in the prevention of cardiac death after myocardial infarction. The Anturane Reinfarction Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0031-6989%2878%2980053-8

7 January 2021

Identifiers

1 reference

25 September 2017

1 reference